glp 1 and cardiovascular benefits GLP-1 medications are rewriting the rules of medicine. A landmark meta-analysis of 99,599 patients found: ✓ 20% reduction in major cardiovascular events ✓ 12% reduction in all-cause death ✓ 15% reduction GLP-1 receptor agonists for cardiovascular

You might also experience vomiting, diarrhea, or constipation

Jakubowska A, Roux CWL, Viljoen A

If people choose, 'Hey, I'd like to try to submit this to my insurance,' we'll give the prescription to do that

Potential clinical outcomes include: 5 Loss of lean body mass with reduced resting metabolic rate Compromised bone mineral density Anemia, fatigue, cognitive changes Impaired immune and antioxidant defenses Slowed detoxification capacity due to inadequate phytonutrient intake Such cumulative effects not only threaten physiological stability but also diminish patient satisfaction, adherence, and long-term therapeutic success